Literature DB >> 10081614

The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans.

I Wessler1, C J Kirkpatrick, K Racké.   

Abstract

1. Acetylcholine (ACh) represents one of the most exemplary neurotransmitters. In addition to its presence in neuronal tissue, there is increasing experimental evidence that ACh is widely expressed in pro- and eukaryotic non-neuronal cells. Thus, ACh has been detected in bacteria, algae, protozoa, tubellariae and primitive plants, suggesting an extremely early appearance of ACh in the evolutionary process. 2. In humans, ACh and/or the synthesizing enzyme, choline acetyltransferase, has been demonstrated in epithelial cells (airways, alimentary tract, urogenital tract, epidermis), mesothelial (pleura, pericardium) and endothelial and muscle cells. In addition, immune cells express the non-neuronal cholinergic system (i.e. the synthesis of ACh can be detected in human leucocytes (granulocytes, lymphocytes and macrophages)), as well as in rat microglia in vitro. 3. The widespread expression of non-neuronal ACh is accompanied by the ubiquitous expression of cholinesterase activity, which prevents ACh from acting as a classical hormone. 4. Non-neuronal ACh mediates its cellular actions in an auto- and paracrine manner via the activation of the widely expressed nicotinic and muscarinic acetylcholine receptors, which can interfere with virtually all cellular signalling pathways (ion channels and key enzymes). 5. Non-neuronal ACh appears to be involved in the regulation of basic cell functions, such as mitosis, cell differentiation, organization of the cytoskeleton, cell-cell contact, secretion and absorption. Non-neuronal ACh also plays a role in the regulation of immune functions. All these qualities together may mediate the so-called 'trophic property' of ACh. 6. Future experiments should be designed to analyse the cellular effects of ACh in greater detail. The involvement of the non-neuronal cholinergic system in the pathogenesis of chronic inflammatory diseases should be investigated to open up new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081614     DOI: 10.1046/j.1440-1681.1999.03016.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  71 in total

1.  Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters.

Authors:  I Wessler; E Roth; C Deutsch; P Brockerhoff; F Bittinger; C J Kirkpatrick; H Kilbinger
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin.

Authors:  N Bernardini; S K Sauer; R Haberberger; M J Fischer; P W Reeh
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

3.  A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.

Authors:  Christopher Heeschen; Michael Weis; Alexandra Aicher; Stefanie Dimmeler; John P Cooke
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.

Authors:  Jan Bucerius; Christoph Manka; Jörn Schmaljohann; Venkatesh Mani; Daniela Gündisch; James H F Rudd; Rolf Bippus; Felix M Mottaghy; Ullrich Wüllner; Zahi A Fayad; Hans-Jürgen Biersack
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

5.  Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants.

Authors:  Samuel P Fletcher; Brian C Geyer; Amy Smith; Tama Evron; Lokesh Joshi; Hermona Soreq; Tsafrir S Mor
Journal:  Plant Mol Biol       Date:  2004-05       Impact factor: 4.076

Review 6.  Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.

Authors:  John P Cooke
Journal:  Life Sci       Date:  2007-02-17       Impact factor: 5.037

7.  The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.

Authors:  David Cassiman; Louis Libbrecht; Nicoletta Sinelli; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 8.  Endothelial nicotinic acetylcholine receptors and angiogenesis.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

9.  Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions.

Authors:  F A Carvalho; J P Lopes de Almeida; T Freitas-Santos; C Saldanha
Journal:  J Membr Biol       Date:  2009-03-18       Impact factor: 1.843

10.  Chronic exposure to nicotine impairs cholinergic angiogenesis.

Authors:  Hakuoh Konishi; Jenny Wu; John P Cooke
Journal:  Vasc Med       Date:  2009-09-24       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.